Source: Reuters (via feed)
Eli Lilly’s newly launched obesity pill, Foundayo, was prescribed 1,390 times in the United States during the week ended April 10, according to an analyst who cited IQVIA data.
The prescription data was reported for the debut week of the drug in the US market.
No additional data on sales or other metrics was provided in the report.
BizTrendWire Insight:
Prescription counts provide quantifiable data points on pharmaceutical drug utilization.
Prescription counts provide quantifiable data points on pharmaceutical drug utilization.
